课题基金 / 基金详情

A5229A PHASE II/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URIDI

A5229A PHASE II/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URIDI
A5229A URIDI 的 II/III 期、随机、双盲、安慰剂对照试验
批准号:
7606094
负责人:
Henry H. BALFOUR
金额:
$0.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

Henry H. BALFOUR的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective is to look at the effect of uridine on limb fat by comparing changes from baseline to week 48 in DEXA-measured limb fat between the uridine arm and the placebo arm.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG A5142: A PHASE III, RANDOMIZED, OPEN-LABEL COMPARISON OF LOPINAVIR/RITONAVI
  • 批准号:
    7605983
  • 项目类别:
  • 资助金额:
    $0.33万
  • 财政年份:
    2006
  • 负责人:
    Henry H. BALFOUR
  • 依托单位:
ACTG A5163: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ON
  • 批准号:
    7605997
  • 项目类别:
  • 资助金额:
    $0.22万
  • 财政年份:
    2006
  • 负责人:
    Henry H. BALFOUR
  • 依托单位:
COMPLICATIONS OF HIV DISEASE AGENDA
  • 批准号:
    6267903
  • 项目类别:
  • 资助金额:
    $17.35万
  • 财政年份:
    1998
  • 负责人:
    Henry H. BALFOUR
  • 依托单位:
HIV DISEASE RESEARCH AGENDA
  • 批准号:
    6267902
  • 项目类别:
  • 资助金额:
    $17.35万
  • 财政年份:
    1998
  • 负责人:
    Henry H. BALFOUR
  • 依托单位: